Comments (10)

Oct 9, 2022 - 5:46pm
WSO Monkey Bot, what's your opinion? Comment below:

IBGOD22, bummer your thread hasn't had a response yet. Maybe one of these threads could point you in the right direction:

More suggestions...

If those topics were completely useless, don't blame me, blame my programmers...

Most Helpful
  • Associate 1 in IB - ECM
Oct 12, 2022 - 9:31am

I've heard excessively negative things about the culture of their Healthcare IB team in NYC. I know of one person in particular that turned down an offer because he said he reached out to alums on LinkedIn and nearly all of them had shitty things to say about the group. 

Also, maybe my settings only show US deals, but if I look at their transaction history on CapIQ for 2022 it's awfully crummy. They're an Equities business through and through and equity capital markets activity for unprofitable biotech companies is NOT doing well right now. They crushed in 2021 due to a strong SPAC practice (think they made it to number 2 or 3 on the league table) and due to all of the small little Biotech follow-on type of deals they do. Both of those wells have totally dried up. 

I only see six deals closed in 2022 and all were either low-level co-mgr roles, tiny ATM deals and/or an offering of debt for Cantor Fitz itself

image-20221012093510-1

  • Analyst 1 in PE - Growth
Oct 13, 2022 - 3:20am

Just sayin, but Cantor gutted my SA 3 years ago in April. 

Oct 14, 2022 - 3:15am
Bankererer, what's your opinion? Comment below:

Cantor doesn't really have an HC group in London. The PEI group is largely based out of London and has been doing pretty well across sectors, particularly strong in renewables and transport. 

  • Analyst 1 in IB - Cov
Nov 24, 2022 - 7:09am

Facilis quasi quisquam aliquam qui voluptatem similique repellendus. Magnam deleniti commodi sit quia. Ipsa dolorem enim laudantium ad.

Temporibus non officiis numquam est molestiae distinctio cumque. Culpa voluptatem suscipit consequatur facilis officia dolorum aut. Quibusdam maiores saepe et.

Start Discussion

Career Advancement Opportunities

November 2022 Investment Banking

  • Jefferies & Company (▲08) 99.6%
  • Lincoln International (= =) 99.3%
  • Financial Technology Partners (+ +) 98.9%
  • Evercore (▽01) 98.5%
  • Bank of America Merrill Lynch (▲01) 98.1%

Overall Employee Satisfaction

November 2022 Investment Banking

  • PJT Partners (= =) 99.6%
  • Evercore (▲02) 99.3%
  • Greenhill (▲05) 98.9%
  • Canaccord Genuity (▲15) 98.5%
  • William Blair (= =) 98.1%

Professional Growth Opportunities

November 2022 Investment Banking

  • PwC Corporate Finance (▲14) 99.6%
  • Lincoln International (▲03) 99.3%
  • Jefferies & Company (▲04) 98.9%
  • William Blair (▽02) 98.5%
  • Evercore (▽01) 98.2%

Total Avg Compensation

November 2022 Investment Banking

  • Director/MD (10) $613
  • Vice President (38) $392
  • Associates (219) $256
  • 2nd Year Analyst (139) $163
  • 3rd+ Year Analyst (19) $160
  • 1st Year Analyst (464) $153
  • Intern/Summer Associate (88) $151
  • Intern/Summer Analyst (336) $92